Unknown

Dataset Information

0

Characterising covalent warhead reactivity.


ABSTRACT: Many drugs currently used are covalent inhibitors and irreversibly inhibit their targets. Most of these were discovered through serendipity. Covalent inhibitions can have many advantages from a pharmacokinetic perspective. However, until recently most organisations have shied away from covalent compound design due to fears of non-specific inhibition of off-target proteins leading to toxicity risks. However, there has been a renewed interest in covalent modifiers as potential drugs, as it possible to get highly selective compounds. It is therefore important to know how reactive a warhead is and to be able to select the least reactive warhead possible to avoid toxicity. A robust NMR based assay was developed and used to measure the reactivity of a variety of covalent warheads against serine and cysteine - the two most common targets for covalent drugs. A selection of these warheads also had their reactivity measured against threonine, tyrosine, lysine, histidine and arginine to better understand our ability to target non-traditional residues. The reactivity was also measured at various pHs to assess what effect the environment in the active site would have on these reactions. The reactivity of a covalent modifier was found to be very dependent on the amino acid residue.

SUBMITTER: Martin JS 

PROVIDER: S-EPMC6538824 | biostudies-other | 2019 May

REPOSITORIES: biostudies-other

altmetric image

Publications

Characterising covalent warhead reactivity.

Martin James S JS   MacKenzie Claire J CJ   Fletcher Daniel D   Gilbert Ian H IH  

Bioorganic & medicinal chemistry 20190403 10


Many drugs currently used are covalent inhibitors and irreversibly inhibit their targets. Most of these were discovered through serendipity. Covalent inhibitions can have many advantages from a pharmacokinetic perspective. However, until recently most organisations have shied away from covalent compound design due to fears of non-specific inhibition of off-target proteins leading to toxicity risks. However, there has been a renewed interest in covalent modifiers as potential drugs, as it possibl  ...[more]

Similar Datasets

| S-EPMC9645389 | biostudies-literature
| S-EPMC9812368 | biostudies-literature
| S-EPMC7067244 | biostudies-literature
| S-EPMC7521642 | biostudies-literature
| S-EPMC9940781 | biostudies-literature
| S-EPMC2796251 | biostudies-literature
2021-05-06 | PXD020073 | Pride
| S-EPMC6214621 | biostudies-literature
| S-EPMC8183569 | biostudies-literature
| S-EPMC6175077 | biostudies-literature